Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment.

Beretta S, Coppo A, Bianchi E, Zanchi C, Carone D, Stabile A, Padovano G, Sulmina E, Grassi A, Bogliun G, Foti G, Ferrarese C, Pesenti A, Beghi E, Avalli L.

Epilepsy Behav. 2019 Jul 9. pii: S1525-5050(19)30481-0. doi: 10.1016/j.yebeh.2019.06.018. [Epub ahead of print]

PMID:
31300383
2.

Prognostic patterns and predictors in epilepsy: a multicentre study (PRO-LONG).

Beghi E, Beretta S, Carone D, Zanchi C, Bianchi E, Pirovano M, Trentini C, Padovano G, Colombo M, Cereda D, Scanziani S, Giussani G, Gasparini S, Bogliun G, Ferrarese C; PRO-LONG Study Group.

J Neurol Neurosurg Psychiatry. 2019 Jun 27. pii: jnnp-2019-320883. doi: 10.1136/jnnp-2019-320883. [Epub ahead of print]

PMID:
31248935
3.

Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment.

Beretta S, Coppo A, Bianchi E, Zanchi C, Carone D, Stabile A, Padovano G, Sulmina E, Grassi A, Bogliun G, Foti G, Ferrarese C, Pesenti A, Beghi E, Avalli L.

Neurology. 2018 Dec 4;91(23):e2153-e2162. doi: 10.1212/WNL.0000000000006615. Epub 2018 Oct 31.

PMID:
30381366
4.

Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study.

Beretta S, Padovano G, Stabile A, Coppo A, Bogliun G, Avalli L, Ferrarese C.

Epilepsia. 2018 Oct;59 Suppl 2:243-248. doi: 10.1111/epi.14492. Epub 2018 Aug 29.

PMID:
30159874
5.

Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study.

Beretta S, Carone D, Zanchi C, Bianchi E, Pirovano M, Trentini C, Padovano G, Colombo M, Cereda D, Scanziani S, Giussani G, Gasparini S, Bogliun G, Ferrarese C, Beghi E; PRO-LONG Study Group.

Epilepsia. 2017 Sep;58(9):1518-1523. doi: 10.1111/epi.13854. Epub 2017 Aug 8.

6.

Primary headache and epilepsy: a multicenter cross-sectional study.

Tonini MC, Giordano L, Atzeni L, Bogliun G, Perri G, Saracco MG, Tombini M, Torelli P, Turazzini M, Vernieri F, Aguggia M, Bussone G, Beghi E; EPICEF Group.

Epilepsy Behav. 2012 Mar;23(3):342-7. doi: 10.1016/j.yebeh.2012.01.017. Epub 2012 Feb 28.

PMID:
22377332
7.

Risk factors for a first epileptic seizure symptomatic of brain tumour or brain vascular malformation. A case control study.

Leone MA, Ivashynka AV, Tonini MC, Bogliun G, Montano V, Ravetti C, Gambaro P, Paladin F, Beghi E; ARES (Alcohol Related Seizures) study group.

Swiss Med Wkly. 2011 Jan 28;141:w13155. doi: 10.4414/smw.2011.13155. eCollection 2011.

8.

Early versus late remission in a cohort of patients with newly diagnosed epilepsy.

Del Felice A, Beghi E, Boero G, La Neve A, Bogliun G, De Palo A, Specchio LM.

Epilepsia. 2010 Jan;51(1):37-42. doi: 10.1111/j.1528-1167.2009.02141.x. Epub 2009 Jun 1.

9.

Risk factors for a first epileptic seizure after stroke: a case control study.

Leone MA, Tonini MC, Bogliun G, Gionco M, Tassinari T, Bottacchi E, Beghi E; ARES (Alcohol Related Seizures) Study Group.

J Neurol Sci. 2009 Feb 15;277(1-2):138-42. doi: 10.1016/j.jns.2008.11.004. Epub 2008 Dec 6.

PMID:
19059614
10.

Epileptogenic drugs: a systematic review.

Ruffmann C, Bogliun G, Beghi E.

Expert Rev Neurother. 2006 Apr;6(4):575-89. Review.

PMID:
16623656
11.

Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy.

Comi C, Gaviani P, Leone M, Ferretti M, Castelli L, Mesturini R, Ubezio G, Chiocchetti A, Osio M, Muscia F, Bogliun G, Corso G, Gavazzi A, Mariani C, Cantello R, Monaco F, Dianzani U.

J Peripher Nerv Syst. 2006 Mar;11(1):53-60.

PMID:
16519782
12.

Predictors of epilepsy surgery outcome: a meta-analysis.

Tonini C, Beghi E, Berg AT, Bogliun G, Giordano L, Newton RW, Tetto A, Vitelli E, Vitezic D, Wiebe S.

Epilepsy Res. 2004 Nov;62(1):75-87.

PMID:
15519134
13.

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.

Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Franchi D, La Presa MT, Lissoni A, Buda A, Fei F, Cundari S, Zanna C.

Ann Oncol. 2004 Sep;15(9):1439-42.

PMID:
15319252
14.

Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996.

Bogliun G, Beghi E; Italian GBS Registry Study Group.

Acta Neurol Scand. 2004 Aug;110(2):100-6.

PMID:
15242417
15.

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale.

Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Parma G, Lissoni A, Fei F, Cundari S, Zanna C.

Neurology. 2003 Nov 11;61(9):1297-300.

PMID:
14610145
16.

Emotional and affective disturbances in patients with epilepsy.

Beghi E, Spagnoli P, Airoldi L, Fiordelli E, Appollonio I, Bogliun G, Zardi A, Paleari F, Gamba P, Frattola L, Da Prada L.

Epilepsy Behav. 2002 Jun;3(3):255-261.

PMID:
12662606
17.

Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis.

Beghi E, Balzarini C, Bogliun G, Logroscino G, Manfredi L, Mazzini L, Micheli A, Millul A, Poloni M, Riva R, Salmoiraghi F, Tonini C, Vitelli E; Italian ALS Study Group.

Neuroepidemiology. 2002 Nov-Dec;21(6):265-70.

PMID:
12411728
18.

Chronic alcohol use and first symptomatic epileptic seizures.

Leone M, Tonini C, Bogliun G, Monaco F, Mutani R, Bottacchi E, Gambaro P, Rocci E, Tassinari T, Cavestro C, Beghi E.

J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):495-9.

19.

Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barrè syndrome.

Bogliun G, Beghi E; Guillain-Barrè Syndrome Registry Study Group.

Neurol Sci. 2002 Sep;23(3):113-7.

PMID:
12391495
20.

Rational use of EEG in adults in clinical practice.

Airoldi L, Beghi E, Bogliun G, Crespi V, Frattola L.

J Clin Neurophysiol. 1999 Sep;16(5):456-61.

PMID:
10576228
21.

Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients.

Cavaletti G, Bogliun G, Zincone A, Marzorati L, Melzi P, Frattola L, Marzola M, Bonazzi C, Cantù MG, Chiari S, Galli A, Bregni M, Gianni MA.

Anticancer Res. 1998 Sep-Oct;18(5B):3797-802.

PMID:
9854499
22.

Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients.

Ferrarese C, Cogliati T, Tortorella R, Zucca C, Bogliun G, Beghi E, Passoni D, Zoia C, Begni B, Airoldi L, Alho H, Frattola L.

Epilepsy Res. 1998 Jan;29(2):129-34.

PMID:
9477145
23.

Risk factors for the development of severe cisplatin neurotoxicity.

Bogliun G, Marzorati L, Zincone A, Crespi V, Frattola L, Tredici G, Cavaletti G.

Int J Oncol. 1997 Aug;11(2):365-70.

PMID:
21528223
24.

Decreased density of lymphocyte benzodiazepine receptors in drug-resistant epileptic patients.

Ferrarese C, Tortorella R, Bogliun G, Beghi E, Cogliati T, Zoia C, Passoni D, Frattola L.

Epilepsy Res. 1997 Jun;27(3):181-5.

PMID:
9237052
25.

Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients.

Drlicek M, Bianchi G, Bogliun G, Casati B, Grisold W, Kolig C, Liszka-Setinek U, Marzorati L, Wondrusch E, Cavaletti G.

J Neurol. 1997 Feb;244(2):85-9.

PMID:
9120501
26.

Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer.

Cavaletti G, Bogliun G, Crespi V, Marzorati L, Zincone A, Marzola M, Rota S, Galli A, Tredici P, Tredici G.

J Clin Oncol. 1997 Jan;15(1):199-206.

PMID:
8996143
27.
28.

Autonomic neuropathy in ulcerative colitis.

Zincone A, Bogliun G, Crespi V, Marzorati L, D'Angelo L, Beretta L, Liverani A, Panelli MR.

Scand J Gastroenterol. 1995 Apr;30(4):399-400. No abstract available.

PMID:
7610358
29.

Weekly cisplatin +/- glutathione in relapsed ovarian carcinoma.

Colombo N, Bini S, Miceli D, Bogliun G, Marzorati L, Cavaletti G, Parmigiani F, Venturino P, Tedeschi M, Frattola L, Buratti C, Mangioni C.

Int J Gynecol Cancer. 1995 Mar;5(2):81-86.

PMID:
11578459
30.

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin.

Cavaletti G, Bogliun G, Marzorati L, Zincone A, Marzola M, Colombo N, Tredici G.

Cancer. 1995 Mar 1;75(5):1141-50.

PMID:
7850713
31.

Long-term peripheral neurotoxicity of cisplatin in patients with successfully treated epithelial ovarian cancer.

Cavaletti G, Bogliun G, Marzorati L, Tredici G, Colombo N, Parma G, Miceli MD.

Anticancer Res. 1994 May-Jun;14(3B):1287-92.

PMID:
8067698
32.

Epilepsy and psychiatric disturbance. A cross-sectional study.

Fiordelli E, Beghi E, Bogliun G, Crespi V.

Br J Psychiatry. 1993 Oct;163:446-50.

PMID:
8252283
33.
34.

Clinical and neurophysiologic evaluation of the effect of Cisplatin administration on the motor nerves.

Marzorati L, Bogliun G, Cavaletti G.

Int J Oncol. 1993 Jan;2(1):81-4.

PMID:
21573518
35.

Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.

Bogliun G, Marzorati L, Cavaletti G, Frattola L.

Ital J Neurol Sci. 1992 Nov;13(8):643-7.

PMID:
1336008
36.

Cerebrovascular disorders and alcohol intake: preliminary results of a case-control study.

Beghi E, Bogliun G, Cosso P, Fiorelli G, Lorini C, Mandelli M, Romano R, Sanguineti I.

Ital J Neurol Sci. 1992 Apr;13(3):209-14.

PMID:
1624276
37.

Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity.

Cavaletti G, Marzorati L, Bogliun G, Colombo N, Marzola M, Pittelli MR, Tredici G.

Cancer. 1992 Jan 1;69(1):203-7.

PMID:
1309303
38.

The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer.

Cavaletti G, Bogliun G, Marzorati L, Marzola M, Pittelli MR, Tredici G.

J Neurol. 1991 Oct;238(7):371-4.

PMID:
1960541
39.

Usefulness and significance of the concept of leukoaraiosis in the study of dementia.

Sanguineti I, Beghi E, Bogliun G.

Ital J Neurol Sci. 1990 Oct;11(5):429-35. Review. No abstract available.

PMID:
2272778
40.

MRI evaluation of a case of herpes zoster ophthalmicus with delayed contralateral hemiplegia.

Cavaletti G, Bogliun G, Tagliabue M.

Ital J Neurol Sci. 1990 Jun;11(3):297-300.

PMID:
2387702
41.

Adrenoleukodystrophy. Report of a case with extremely slow progression of symptoms.

Cavaletti G, Bogliun G, Tredici G.

Acta Neurol (Napoli). 1990 Apr;12(2):109-14.

PMID:
2360475
42.

Hypothyroidism and polyneuropathy.

Beghi E, Delodovici ML, Bogliun G, Crespi V, Paleari F, Gamba P, Capra M, Zarrelli M.

J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1420-3.

43.

Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study.

Beghi E, Bogliun G, Cavaletti G, Sanguineti I, Tagliabue M, Agostoni F, Macchi I.

Acta Neurol Scand. 1989 Sep;80(3):226-31.

PMID:
2801019
44.

Aphasia and apraxia caused by ischemic damage to the white substance of the dominant hemisphere.

Sanguineti I, Agostoni E, Aiello U, Apale P, Bogliun G, Tagliabue M.

Ital J Neurol Sci. 1989 Feb;10(1):97-100.

PMID:
2925350
45.

Ataxic hemiparesis syndrome: sensory disturbances and somatosensory evoked potentials.

Crespi V, Bogliun G, Delodovici ML, Sanguineti I.

Ital J Neurol Sci. 1988 Oct;9(5):459-66.

PMID:
3215746
46.

Sporadic adult onset distal myopathy.

Cavaletti G, Bogliun G, Apale P, Iredici G, Moggio M.

J Neurol Neurosurg Psychiatry. 1988 Mar;51(3):468-9. No abstract available.

47.

[Claude's syndrome].

Sanguineti I, Tagliabue M, Bogliun G, Cavaletti G, Crespi V, Delodovici ML.

Rev Neurol (Paris). 1988;144(12):840-1. French. No abstract available.

PMID:
3238252
48.

Anticonvulsant drugs and bone metabolism.

Bogliun G, Beghi E, Crespi V, Delodovici L, d'Amico P.

Acta Neurol Scand. 1986 Oct;74(4):284-8.

PMID:
3811834
49.

Ataxic hemiparesis syndrome: clinical and CT study of 20 new cases and review of the literature.

Sanguineti I, Tredici G, Beghi E, Aiello U, Bogliun G, Di Lelio A, Tagliabue M.

Ital J Neurol Sci. 1986 Feb;7(1):51-9.

PMID:
3957633
50.

[Cisplatin polyneuropathy].

Beghi E, Bogliun G, Crespi V, Delodovici ML, Landoni F.

Riv Neurobiol. 1984 Apr-Sep;30(2-3):431-7. Italian. No abstract available.

PMID:
6100526

Supplemental Content

Loading ...
Support Center